Kinases catalyze the transfer of the γ-phosphate from adenosine 5´-triphosphate (ATP) to proteins, lipids, sugars, or other acceptors. This process, termed phosphorylation, forms the cornerstone of ...
The CellTiter-Glo ® 2.0 Cell Viability Assay is a luminescent method for swift, convenient, routine cell viability assessments. Offers equivalent performance to the classic CellTiter-Glo ® Cell ...
CyberKnife concomitant with neoadjuvant chemotherapy for breast tumor: Phase I. Background: Chemotherapy (Ctx) for primary breast cancer (PBC) now utilizes expensive drugs, thus emerging important ...
MADISON, Wis.--(BUSINESS WIRE)--Promega Corporation launches a new assay validated for assessing the viability of cells in three-dimensional (3D) microtissue model systems. CellTiter-Glo® 3D Cell ...
Luminescence screening assays have become a central component of modern drug discovery workflows, particularly in high-throughput screening (HTS) environments. These assays enable rapid, sensitive ...
There is growing use of three-dimensional (3D) cell culture models to attempt to reproduce cell-to-cell and cell-to-matrix interactions occurring in vivo. The goal is to create model systems for ...
A phase II trial of thalidomide (T), irinotecan (I) and gemcitabine (G) in chemonaive patients (pts) with advanced non-small cell lung cancer (NSCLC) No significant financial relationships to disclose ...
The development of new therapeutics targeting protein kinases is crucial in the fight against diseases like cancer. Kinase drug discovery programs rely on the precise characterization and screening of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results